Neurology Solutions leads Parkinson’s panel
Dr. Robert Izor and the Neurology Solutions provider team participate in a panel discussion on a range of Parkinson treatments during the August meeting of the Capital Area Parkinson’s Society.
Dr. Robert Izor and the Neurology Solutions provider team participate in a panel discussion on a range of Parkinson treatments during the August meeting of the Capital Area Parkinson’s Society.
A growing body of evidence suggests that high levels of moderate to vigorous exercise may be a key interventional and neuroprotective therapy to slow progression of Parkinson’s disease (PD). Likewise, PD experts agree that physical activity is beneficial to PD patients at most stages of their disease, including at early diagnosis.
Therapeutic Botulinum toxin, commonly referred to as “Botox therapy,” and other nerve blocks have been successfully used to treat neurological and musculoskeletal disorders such as dystonia, spasticity and cerebral palsy for the past 30+ years. Learn how Botox Therapy is used to manage spasms, stiffness and muscle pain associated with debilitating neurological disorders.
Neurology Solutions Physical Therapist shares Deep Brain Stimulation research, the common misconceptions behind the surgery and success stories she has witnessed.
As people age, muscle degeneration occurs, and strength, and thus balance, becomes impaired. People who lead a sedentary lifestyle can lose about half their strength and about 40% of their muscle, which leads to a loss of balance as well.
Stroke is one of the leading causes of death in the United States; however, it is largely preventable and treatable. Learn about stroke risks, stroke prevention, how to identify a stroke and recovery.
New legislation to create a national data collection system for Parkinson’s disease and other neurological disorders to support better research and services will be discussed during an upcoming meeting of the Capital Area Parkinson’s Society. Supported by the Parkinson’s Action Network, the H.R. 292 bill would allow for collection of data such as the geography of diagnoses, variances in gender, disease burden and changes in healthcare practices among patients to be used in a range of research initiatives and in evaluating and planning our nation’s health care needs,
Parkinson’s Disease Awareness Month is putting a spotlight on a neurological disorder affecting more than one million Americans and an estimated 7 to 10 million people worldwide.
Parkinson’s Disease (or PD) is a progressive disorder of the central nervous system that gradually affects patients’ movements through tremors, stiffness or slowing of movement. PD impacts nerve cells in a part of the brain called the substantia nigra impairing the cells’ ability to produce and deliver the neurotransmitter dopamine to other cells. In fact, by the time early Parkinson’s disease is diagnosed, it is estimated the person has lost 70 percent of the cells that produce dopamine.
We all know that adequate sleep plays an important role in our health and ability to function effectively each day. But what you may not know is that sleep problems such as insomnia, excessive daytime sleepiness and nightmares may be an early sign of Parkinson’s disease (PD), even before motor symptoms have begun (National Sleep Foundation).